Fujirebio is launching a human cerebrospinal fluid (CSF) assay in its continuing efforts to detect Alzheimer’s ...
Alzheimer’s disease (AD) is characterized by the accumulation of neurofibrillary tangles in the brain, composed of hyperphosphorylated tau, and amyloid plaques, consisting of distinct β-amyloid ...
A new finger prick test claims to detect Alzheimer’s with 91% accuracy using p-tau217 biomarkers. Learn how this accessible ...
Indias first AI-integrated blood biomarker test with PET and MRI imaging shows promises with early Alzheimers detection, ...
Early diagnosis of Alzheimer’s disease is now possible well before severe cognitive symptoms appear, with the help of a new ...
Researchers at the new Center for Brain Health at UT Health San Antonio are studying midlife testing for early-onset dementia with blood-based biomarkers to see if they can detect disease activity up ...
Mahajan Imaging & Labs introduces Alzheimer’s Diagnostics with AI-integrated blood biomarker testing
Mahajan Imaging & Labs has expanded its Alzheimer’s diagnostic capabilities with the introduction of an AI-integrated blood ...
A pioneering trial has begun to assess whether a simple finger-prick blood test could offer an early diagnosis for ...
GlobalData on MSN
RevBio receives FDA clearance for cranial bone glue trial
The FDA has authorised up to 15 clinical sites to take part in the study.
New potential for Alzheimer disease biomarker testing found in dried blood collection derived from capillary blood.
A quick blood test could replace the current invasive methods of diagnosing the disease and it could be performed in GP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results